Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Adenocarcinoma Of Esophagus × Immune Checkpoint Inhibitors × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 20 Carcinoma, Hepatocellular 11 Neoplasms 7 Melanoma 7 Neoplasm Metastasis 6 Triple Negative Breast Neoplasms 5 Stomach Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 5 Colonic Neoplasms 5 Nasopharyngeal Carcinoma 4 Colorectal Neoplasms 4 Small Cell Lung Carcinoma 3 Recurrence 3 Rectal Neoplasms 3 Pancreatic Neoplasms 3 Lung Neoplasms 3 Head and Neck Neoplasms 3 Esophageal Neoplasms 3 Carcinoma, Renal Cell 3 Solid Cancers 2 Skin Neoplasms 2 Prostatic Neoplasms 2 Pathologic Complete Response 2 Parkinson Disease 4, Autosomal Dominant Lewy Body 2 Ovarian Neoplasms 2 Gastric / Gastroesophageal Junction Adenocarcinoma 2 Esophageal Squamous Cell Carcinoma 2 EBV-associated Tumors 2 Breast Neoplasms 2 Bites and Stings 2

Interventions

Fluorouracil 14 Oxaliplatin 12 Nivolumab 11 Leucovorin 11 Capecitabine 9 Paclitaxel 8 pembrolizumab 7 Radiation 5 Irinotecan 5 durvalumab 4 Trastuzumab 4 Taxes 4 Specimen Handling 4 Radiotherapy 4 Cisplatin 4 Carboplatin 4 Biopsy 4 dehydroftorafur 3 Endoscopy 3 Drug Therapy 3 Docetaxel 3 zimberelimab 2 zanidatamab 2 tremelimumab 2 tislelizumab 2 Ramucirumab 2 Magnetic Resonance Spectroscopy 2 Folfox protocol 2 zolbetuximab 1 tucatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡